Gestational Trophoblastic Disease: all 57 studies

Page 1 of 1. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform MoleNot yet recruitingNCT07333326
• Clinicopathological Features , Outcomes and Prognostic Factors of High Risk Patients of Gestational Trophoblastic NeoplasiaNot yet recruitingNCT06900699
• Clinical Specialty Queue For Gestational Trophoblastic NeoplasiaRecruitingNCT06681259
• Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium StudyRecruitingNCT06284980
• The Psychological Impact of GTN on Women Who Have Completed Chemotherapy TreatmentRecruitingNCT06169644
• Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6RecruitingNCT06028672Not applicable
• Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7RecruitingNCT06020755Phase 2
• A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic NeoplasiaRecruitingNCT05635344Phase 2
• Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic NeoplasiaRecruitingNCT05139095Phase 2
• Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined ChemotherapyRecruitingNCT04812002Phase 2
• Second Uterine Evacuation for Low-risk Gestational Trophoblastic NeoplasiaRecruitingNCT04756713Phase 3
• Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line TreatmentRecruitingNCT04396223Phase 1/2
• Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung NoduleRecruitingNCT03785574Not applicable
• Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic NeoplasiaRecruitingNCT03703271Phase 2
• The French National Reference Centre of GTDRecruitingNCT02892877
• Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic TumorRecruitingNCT02639650Phase 3
• Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)TerminatedNCT02664961Phase 2Results posted
• Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantCompletedNCT00293384Not applicableResults posted
• IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE CancersActive, not recruitingNCT06790706Phase 2
• ASk Questions in GYnecologic Oncology (ASQ-GYO)CompletedNCT06339827Not applicable
• Dostarlimab in Chemoresistant Gestational Trophoblastic NeoplasiaWithdrawnNCT05405192Phase 2
• Letrozole as a Prophylaxis From GTN for Complete Mole PatientsStatus unknownNCT05203562Phase 2/3
• Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic NeoplasiaActive, not recruitingNCT04562558Not applicable
• Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP)Status unknownNCT04303884Phase 2
• Camrelizumab Combined With Apatinib for Recurrent Resistant GTNCompletedNCT04047017Phase 2
• The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
• Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6Status unknownNCT03885388Phase 2/3
• Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic NeoplasiaStatus unknownNCT03280979Phase 2/3
• Avelumab in Chemo-resistant Gestational Trophoblastic NeoplasiasCompletedNCT03135769Phase 2
• Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
• Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic NeoplasmsStatus unknownNCT02606539Phase 2/3
• Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic CancerCompletedNCT02096783Not applicable
• Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic NeoplasiaStatus unknownNCT01823315Phase 3
• Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
• Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789Not applicable
• Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantCompletedNCT00900406
• Blood Samples From Patients on a Clinical Trial to CINV During HSCTTerminatedNCT00900068
• Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
• A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease SurvivorsCompletedNCT00706875
• T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
• Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantCompletedNCT00410657Phase 2
• Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00324324Phase 3
• Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic DiseaseStatus unknownNCT00166790
• Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
• Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar PregnancyTerminatedNCT00096187Phase 2
• Study of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsCompletedNCT00082654Not applicable
• Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsCompletedNCT00066404Phase 1
• Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00064311Phase 1/2
• Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for CancerCompletedNCT00058071Phase 3
• Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonCompletedNCT00010283Phase 1/2
• Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsCompletedNCT00004157Phase 2
• Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
• Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic NeoplasiaCompletedNCT00003688Phase 2
• Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003597Phase 1
• Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityCompletedNCT00003548Phase 1
• Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerCompletedNCT00003408Phase 2
• Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsCompletedNCT00003107Phase 1

← Gestational Trophoblastic Disease overview